# OptimumBank Holdings, Inc.: financial statements, quarterly

OPHC · NYSE · CIK 1288855 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ophc.md) · [Financials](/companies/ophc/financials.md) · [Filings](/companies/ophc/filings.md) · [Insiders](/companies/ophc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ophc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $k | [2,988](/filings/0001493152-23-040138.md) | [4,035 d](/filings/0001493152-24-009360.md) | [5,714](/filings/0001493152-24-018822.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [459](/filings/0001493152-24-044211.md) | [876 d](/filings/0001493152-25-008332.md) | [847](/filings/0001641172-25-009608.md) | [1,168](/filings/0001641172-25-022770.md) | [1,133](/filings/0001493152-25-021417.md) | [1,360 d](/filings/0001493152-26-008143.md) | [1,326](/filings/0001493152-26-022399.md) | [1,253](/filings/0001493152-26-036825.md) | [1,340](/filings/0001493152-25-021417.md) | [1,604 d](/filings/0001493152-26-008143.md) | [1,535](/filings/0001493152-26-022399.md) | [2,183](/filings/0001493152-26-036825.md) |
| Net income | $k | [1,269](/filings/0001493152-24-044211.md) | [2,549 d](/filings/0001493152-25-008332.md) | [2,377](/filings/0001641172-25-009608.md) | [3,496](/filings/0001641172-25-022770.md) | [3,302](/filings/0001493152-25-021417.md) | [3,951 d](/filings/0001493152-26-008143.md) | [3,870](/filings/0001493152-26-022399.md) | [3,602](/filings/0001493152-26-036825.md) | [4,323](/filings/0001493152-25-021417.md) | [4,853 d](/filings/0001493152-26-008143.md) | [4,663](/filings/0001493152-26-022399.md) | [6,655](/filings/0001493152-26-036825.md) |
| Diluted EPS | $ per share | [0.18](/filings/0001493152-24-044211.md) | not reported | [0.31](/filings/0001641172-25-009608.md) | [0.34](/filings/0001641172-25-022770.md) | [0.15](/filings/0001493152-25-021417.md) | not reported | [0.17](/filings/0001493152-26-022399.md) | [0.15](/filings/0001493152-26-036825.md) | [0.18](/filings/0001493152-25-021417.md) | not reported | [0.20](/filings/0001493152-26-022399.md) | [0.28](/filings/0001493152-26-036825.md) |
| Basic EPS | $ per share | [0.18](/filings/0001493152-24-044211.md) | not reported | [0.31](/filings/0001641172-25-009608.md) | [0.36](/filings/0001641172-25-022770.md) | [0.34](/filings/0001493152-25-021417.md) | not reported | [0.33](/filings/0001493152-26-022399.md) | [0.31](/filings/0001493152-26-036825.md) | [0.37](/filings/0001493152-25-021417.md) | not reported | [0.39](/filings/0001493152-26-022399.md) | [0.40](/filings/0001493152-26-036825.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [713](/filings/0001493152-23-040138.md) | [791](/filings/0001493152-25-008332.md) | [941](/filings/0001493152-24-018822.md) | [900](/filings/0001493152-24-030217.md) | [945](/filings/0001493152-24-044211.md) | [933](/filings/0001493152-26-008143.md) | [977](/filings/0001641172-25-009608.md) | [999](/filings/0001641172-25-022770.md) | [1,083](/filings/0001493152-25-021417.md) | [1,112](/filings/0001493152-26-036825.md) | [1,269](/filings/0001493152-26-022399.md) | [1,401](/filings/0001493152-26-036825.md) |
| Total liabilities | $m | [647](/filings/0001493152-23-040138.md) | [721](/filings/0001493152-25-008332.md) | [858](/filings/0001493152-24-018822.md) | [813](/filings/0001493152-24-030217.md) | [852](/filings/0001493152-24-044211.md) | [830](/filings/0001493152-26-008143.md) | [869](/filings/0001641172-25-009608.md) | [888](/filings/0001641172-25-022770.md) | [966](/filings/0001493152-25-021417.md) | [990](/filings/0001493152-26-036825.md) | [1,142](/filings/0001493152-26-022399.md) | [1,267](/filings/0001493152-26-036825.md) |
| Shareholders' equity | $m | [66.3](/filings/0001493152-24-044211.md) | [70.0](/filings/0001493152-26-008143.md) | [83.0](/filings/0001641172-25-022770.md) | [87.0](/filings/0001493152-25-021417.md) | [92.7](/filings/0001493152-25-021417.md) | [103](/filings/0001493152-26-036825.md) | [108](/filings/0001493152-26-036825.md) | [111](/filings/0001493152-26-036825.md) | [117](/filings/0001493152-25-021417.md) | [122](/filings/0001493152-26-036825.md) | [127](/filings/0001493152-26-036825.md) | [134](/filings/0001493152-26-036825.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1.2 d](/filings/0001493152-24-044211.md) | [0.3 d](/filings/0001493152-25-008332.md) | [2.5](/filings/0001641172-25-009608.md) | [3.1 d](/filings/0001641172-25-022770.md) | [4.0 d](/filings/0001493152-25-021417.md) | [6.0 d](/filings/0001493152-26-008143.md) | [3.1](/filings/0001493152-26-022399.md) | [6.2 d](/filings/0001493152-26-036825.md) | [1.9 d](/filings/0001493152-25-021417.md) | [6.6 d](/filings/0001493152-26-008143.md) | [7.9](/filings/0001493152-26-022399.md) | [10.3 d](/filings/0001493152-26-036825.md) |
| Capital expenditure | $m | [0.1 d](/filings/0001493152-24-044211.md) | [0.2 d](/filings/0001493152-25-008332.md) | [0.3](/filings/0001641172-25-009608.md) | [0.4 d](/filings/0001641172-25-022770.md) | [0.2 d](/filings/0001493152-25-021417.md) | [0.2 d](/filings/0001493152-26-008143.md) | [0.3](/filings/0001493152-26-022399.md) | [0.3 d](/filings/0001493152-26-036825.md) | [0.0 d](/filings/0001493152-25-021417.md) | [0.3 d](/filings/0001493152-26-008143.md) | [0.4](/filings/0001493152-26-022399.md) | [0.5 d](/filings/0001493152-26-036825.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [6.1](/filings/0001493152-23-040138.md) | [7.2](/filings/0001493152-24-018822.md) | [7.3](/filings/0001493152-24-030217.md) | [7.3](/filings/0001493152-24-044211.md) | [7.6](/filings/0001641172-25-009608.md) | [10.2](/filings/0001641172-25-022770.md) | [21.4](/filings/0001493152-25-021417.md) | [23.3](/filings/0001493152-26-022399.md) | [23.4](/filings/0001493152-26-036825.md) | [23.4](/filings/0001493152-25-021417.md) | [23.6](/filings/0001493152-26-022399.md) | [23.7](/filings/0001493152-26-036825.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 12,268,363 at 2026-05-11, from the cover of the [10-Q filed 2026-05-12](/filings/0001493152-26-022399.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:36 ET. No prices; not investment advice.